Eric Yvon

5.3k total citations · 1 hit paper
49 papers, 3.6k citations indexed

About

Eric Yvon is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Eric Yvon has authored 49 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Immunology, 31 papers in Oncology and 9 papers in Genetics. Recurrent topics in Eric Yvon's work include CAR-T cell therapy research (27 papers), Immune Cell Function and Interaction (24 papers) and T-cell and B-cell Immunology (11 papers). Eric Yvon is often cited by papers focused on CAR-T cell therapy research (27 papers), Immune Cell Function and Interaction (24 papers) and T-cell and B-cell Immunology (11 papers). Eric Yvon collaborates with scholars based in United States, France and Italy. Eric Yvon's co-authors include Malcolm K. Brenner, Gianpietro Dotti, Helen E. Heslop, Cliona M. Rooney, Barbara Savoldo, Hao Liu, Martin Pulé, Ettore Biagi, Chrystal U. Louis and Stéphane Vigouroux and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Eric Yvon

47 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma

2011 882 citations Chrystal U. Louis, Barbara Savoldo et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Yvon United States	28	2.6k	1.8k	900	867	698	49	3.6k
Meng-Fen Wu United States	16	2.4k 0.9×	1.0k 0.6×	815 0.9×	743 0.9×	627 0.9×	18	2.9k
Karin Straathof United States	23	3.6k 1.4×	1.9k 1.0×	1.2k 1.4×	1.4k 1.6×	793 1.1×	38	4.6k
Zhuyong Mei United States	22	3.8k 1.5×	1.9k 1.0×	1.2k 1.4×	1.4k 1.6×	1.0k 1.4×	35	4.5k
Carolina Berger United States	28	3.0k 1.2×	1.5k 0.8×	1.2k 1.4×	1.1k 1.3×	782 1.1×	49	3.9k
Olga Dakhova United States	24	2.4k 0.9×	914 0.5×	1.1k 1.2×	822 0.9×	712 1.0×	40	3.1k
Rebecca C. Larson United States	19	1.9k 0.7×	947 0.5×	1.3k 1.4×	630 0.7×	679 1.0×	38	3.1k
Bambi Grilley United States	21	3.7k 1.4×	1.5k 0.8×	1.2k 1.4×	1.5k 1.7×	920 1.3×	69	4.4k
Wen-Chung Chang United States	15	2.3k 0.9×	970 0.5×	687 0.8×	778 0.9×	822 1.2×	18	2.7k
Cindy Delbrook United States	16	2.9k 1.1×	792 0.4×	760 0.8×	880 1.0×	715 1.0×	27	3.3k
Matthew J. Frigault United States	25	2.9k 1.1×	851 0.5×	885 1.0×	717 0.8×	951 1.4×	131	3.4k

Countries citing papers authored by Eric Yvon

Since Specialization

Citations

This map shows the geographic impact of Eric Yvon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Yvon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Yvon more than expected).

Fields of papers citing papers by Eric Yvon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Yvon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Yvon. The network helps show where Eric Yvon may publish in the future.

Co-authorship network of co-authors of Eric Yvon

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Yvon. A scholar is included among the top collaborators of Eric Yvon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Yvon. Eric Yvon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dowlati, Ehsan, Haili Lang, Eugene Hwang, et al.. (2022). Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β. Molecular Therapy — Methods & Clinical Development. 27. 415–430. 28 indexed citations

Balakrishnan, Preethi B., Juliana Cano‐Mejia, Jaclyn Andricovich, et al.. (2021). CD137 agonist potentiates the abscopal efficacy of nanoparticle-based photothermal therapy for melanoma. Nano Research. 15(3). 2300–2314. 28 indexed citations

Burga, Rachel A., Eric Yvon, Elizabeth Chorvinsky, et al.. (2019). Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for Neuroblastoma. Clinical Cancer Research. 25(14). 4400–4412. 69 indexed citations

Kellner, Joshua, Carolina Colli Cruz, Catherine M. Bollard, & Eric Yvon. (2016). Gene Modification of Human Natural Killer Cells Using a Retroviral Vector. Methods in molecular biology. 1441. 203–213. 7 indexed citations

Lukianova‐Hleb, Ekaterina Y., Eric Yvon, Elizabeth J. Shpall, & Dmitri O. Lapotko. (2016). All-in-one processing of heterogeneous human cell grafts for gene and cell therapy. Molecular Therapy — Methods & Clinical Development. 3. 16012–16012. 5 indexed citations

Ciurea, Stefan O., Dean A. Lee, Kai Cao, et al.. (2015). Phase I Trial of IL-21 Ex Vivo Expanded NK Cells Administration to Prevent Disease Relapse after Haploidentical Stem-Cell Transplantation for Myeloid Leukemias. Blood. 126(23). 102–102. 1 indexed citations

Kennedy‐Nasser, Alana A., Stephanie Ku, Yasmin Hazrat, et al.. (2014). Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity. Clinical Cancer Research. 20(8). 2215–2225. 145 indexed citations

Parmar, Simrit, Xiaoying Liu, Amer Najjar, et al.. (2014). Ex vivo fucosylation of third-party human regulatory T cells enhances anti–graft-versus-host disease potency in vivo. Blood. 125(9). 1502–1506. 52 indexed citations

Geldres, Claudia, Barbara Savoldo, Valentina Hoyos, et al.. (2013). T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both In Vitro and In Vivo. Clinical Cancer Research. 20(4). 962–971. 80 indexed citations

10.

Hegde, Meenakshi, Amanda Corder, Kevin Chow, et al.. (2013). Combinational Targeting Offsets Antigen Escape and Enhances Effector Functions of Adoptively Transferred T Cells in Glioblastoma. Molecular Therapy. 21(11). 2087–2101. 299 indexed citations

11.

Parmar, Simrit, Xiaoying Liu, Simon N. Robinson, et al.. (2013). Third-party umbilical cord blood–derived regulatory T cells prevent xenogenic graft-versus-host disease. Cytotherapy. 16(1). 90–100. 45 indexed citations

12.

Ku, Stephanie, Alana A. Kennedy‐Nasser, Yasmin Hazrat, et al.. (2013). Ultra low-dose IL-2 mediated expansion of regulatory T cells as GvHD prophylaxis for recipients of allogeneic hematopoietic stem cells. Cytotherapy. 15(4). S41–S42.

13.

Huye, Leslie E., Yozo Nakazawa, Mayuri Patel, et al.. (2011). Combining mTor Inhibitors With Rapamycin-resistant T Cells: A Two-pronged Approach to Tumor Elimination. Molecular Therapy. 19(12). 2239–2248. 39 indexed citations

14.

Yvon, Eric, Michele Del Vecchio, Barbara Savoldo, et al.. (2009). Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells. Clinical Cancer Research. 15(18). 5852–5860. 113 indexed citations

15.

Ahmed, Nabil, Vita S. Salsman, Eric Yvon, et al.. (2009). Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression. Molecular Therapy. 17(10). 1779–1787. 167 indexed citations

16.

Fujita, Yuriko, Ann M. Leen, Jiali Sun, et al.. (2008). Exploiting Cytokine Secretion to Rapidly Produce Multivirus-specific T Cells for Adoptive Immunotherapy. Journal of Immunotherapy. 31(7). 665–674. 35 indexed citations

17.

Dotti, Gianpietro, Barbara Savoldo, Martin Pulé, et al.. (2005). Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis. Blood. 105(12). 4677–4684. 94 indexed citations

18.

Yvon, Eric, Stéphane Vigouroux, Raphaël F. Rousseau, et al.. (2003). Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells. Blood. 102(10). 3815–3821. 128 indexed citations

19.

Biagi, E., Raphaël F. Rousseau, Eric Yvon, et al.. (2002). Cancer vaccines: dream, reality, or nightmare?. Clinical and Experimental Medicine. 2(3). 109–118. 4 indexed citations

20.

Gahn, B., Fernando Siller-López, Eric Yvon, et al.. (2001). Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: A potential treatment strategy for Epstein-Barr virus-positive Hodgkin's lymphoma. International Journal of Cancer. 93(5). 706–713. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact